Video
Advantages of transperineal biopsies over transrectal biopsies
Author(s):
Video Player is loading.
In this video, Matthew J. Allaway, MD, assesses the differences between the transrectal and transperineal approaches to prostate biopsy and the overall advantage of the transperineal biopsy in detecting cancer and preventing infection. Allaway is the founder and president of Perinealogic, and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Mitchell Huang, MD, on the cost-effectiveness of transperineal vs transrectal prostate biopsy
David Stanley, MD, on current trends in the management of kidney stones
Alicia Morgans, MD, on QOL outcomes with darolutamide plus ADT in mHSPC
Post-RP incontinence: Low procedure rates examined
Roger Dmochowski, MD, on quality-of-life outcomes with the Revi System
Anne Schuckman, MD, highlights promising new developments in NMIBC
Amir Patel, MD, on onabotulinumtoxinA injection at the time of HoLEP
Data link incontinence severity to post-radical prostatectomy care
Margaret Knoedler, MD, on robot-assisted mini-PCNL with the MONARCH Platform
Khurshid Ghani, MBChB, MS, FRCS, on current barriers to stent omission
Related Content
